![](/img/cover-not-exists.png)
PND35 Belgian Cost-Utility Analysis of Gilenya® (Fingolimod) in the Management of Adults with Active Relapsing Remitting Multiple Sclerosis
S. Drieskens, K. MoeremansVolume:
14
Year:
2011
Language:
english
DOI:
10.1016/j.jval.2011.08.501
File:
PDF, 60 KB
english, 2011